polivy
(polatuzumab vedotin)Genentech, Inc.
Usage: POLIVY is indicated for the treatment of adult patients with previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL), and for those with relapsed or refractory DLBCL, NOS, after at least two prior therapies, in combination with specific regimens.